Shares of financial Services company Comerica got downgraded by Goldman Sachs.
Goldman analysts lowered their rating on the stock to sell from neutral. They also slashed their price target on the shares to $70 from $86.
Analyst Ryan Nash cautioned clients in a note that the Federal Reserve’s interest rate cuts could offset Comerica’s commendable actions at boosting loan growth, controlling costs and returning capital. Nash pointed out that Comerica’s disclosures indicate that its NII (net interest income) will decline by 12% from a 200bp decrease in rates (100bp average) compared to its peers' disclosures at a lower 5%. Nash further added that while Comerica has invested in $2.8 billion of swaps to hedge the interest rate risks, his team estimates that the company would need an additional $20 billion-$24 billion to be sufficiently hedged.
According to Nash, several expense advantages in 2019 that helped Comerica to keep costs flat are unlikely to repeat (FDIC costs, GEAR up savings). He also noted that most of its excess capital has been used up.
The Moving Average Convergence Divergence (MACD) for CMA turned positive on June 24, 2025. Looking at past instances where CMA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on CMA as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CMA advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .
CMA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 269 cases where CMA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CMA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock slightly worse than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.192) is normal, around the industry mean (1.037). P/E Ratio (8.402) is within average values for comparable stocks, (16.984). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (2.366). Dividend Yield (0.052) settles around the average of (0.059) among similar stocks. P/S Ratio (2.004) is also within normal values, averaging (2.929).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry RegionalBanks